SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company witnessed a 19.96% growth in the revenue at Rs. 11574.00 millions for the quarter ended March 2025 as compared to Rs. 9648.00 millions during the year-ago period.A slim rise of 22.63% was recorded in the Net profit for the quarter ended March 2025 to Rs. 4281.00  millions  From Rs. 3491.00 millions.Operating profit surged to 6233.00 millions from the corresponding previous quarter of 4886.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 11574.00 9648.00 19.96 40945.00 35689.00 14.73 40945.00 35689.00 14.73
Other Income 621.00 359.00 72.98 3213.00 1047.00 206.88 3213.00 1047.00 206.88
PBIDT 6233.00 4886.00 27.57 24656.00 17417.00 41.56 24656.00 17417.00 41.56
Interest 88.00 45.00 95.56 196.00 145.00 35.17 196.00 145.00 35.17
PBDT 6145.00 4841.00 26.94 24460.00 17272.00 41.62 24460.00 17272.00 41.62
Depreciation 937.00 516.00 81.59 2200.00 1719.00 27.98 2200.00 1719.00 27.98
PBT 5208.00 4325.00 20.42 22260.00 15553.00 43.12 22260.00 15553.00 43.12
TAX 927.00 834.00 11.15 3756.00 2487.00 51.03 3756.00 2487.00 51.03
Deferred Tax -67.00 -2.00 3250.00 -319.00 -361.00 -11.63 -319.00 -361.00 -11.63
PAT 4281.00 3491.00 22.63 18504.00 13066.00 41.62 18504.00 13066.00 41.62
Equity 358.00 358.00 0.00 358.00 358.00 0.00 358.00 358.00 0.00
PBIDTM(%) 53.85 50.64 6.34 60.22 48.80 23.39 60.22 48.80 23.39

Natco Pharma Share Price

1208.75 34.75 (2.96%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×